Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

NCT00460811 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

420

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome With Constipation

Interventions

DRUG: Linaclotide Acetate
DRUG: Matching placebo

Sponsor

Ironwood Pharmaceuticals, Inc.